Holen Sie sich die Stockscreener-App
0.00
100.00%
-17.16
Schlusskurs vom Vortag:
$17.16
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$59.90M
Einnahmen:
$9.16M
Nettoeinkommen (Verlust:
$-68.17M
KGV:
0.00
EPS:
-1.63
Netto-Cashflow:
$-80.16M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$23.28
Ikena Oncology Inc Stock (IKNA) Company Profile
Firmenname
Ikena Oncology Inc
Sektor
Branche
Telefon
857-343-8292
Adresse
50 NORTHERN AVE., BOSTON
Vergleichen Sie IKNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IKNA
Ikena Oncology Inc
|
0.00 | 59.90M | 9.16M | -68.17M | -80.16M | -1.63 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.25 | 105.80B | 11.70B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
646.87 | 67.70B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
440.49 | 57.41B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
851.01 | 51.25B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.68 | 39.86B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ikena Oncology Inc Stock (IKNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-29 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-09-22 | Eingeleitet | Wedbush | Outperform |
| 2023-05-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-12-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-05-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-20 | Eingeleitet | Credit Suisse | Outperform |
| 2021-04-20 | Eingeleitet | Jefferies | Buy |
| 2021-04-20 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Ikena Oncology Inc Aktie (IKNA) Neueste Nachrichten
Analyzing recovery setups for Ikena Oncology Inc. investorsEarnings Summary Report & Free Community Consensus Stock Picks - newser.com
Understanding Ikena Oncology Inc.’s price movementWeekly Trading Summary & Free Expert Approved Momentum Trade Ideas - newser.com
How to recover losses in Ikena Oncology Inc. stockBear Alert & Fast Moving Stock Trade Plans - newser.com
What Fibonacci levels say about Ikena Oncology Inc. reboundTrade Exit Report & Low Drawdown Momentum Trade Ideas - newser.com
Will Ikena Oncology Inc. stock sustain high P E ratios2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
Using fundamentals and technicals on Ikena Oncology Inc.July 2025 Fed Impact & Weekly Setup with ROI Potential - newser.com
Using R and stats models for Ikena Oncology Inc. forecastingGlobal Markets & Technical Buy Zone Confirmations - newser.com
How Ikena Oncology Inc. stock trades during market volatilityJuly 2025 Closing Moves & Stepwise Trade Execution Plans - newser.com
Will Ikena Oncology Inc. stock outperform international peers2025 Market Sentiment & Stock Market Timing Techniques - fcp.pa.gov.br
Why Ikena Oncology Inc. stock is favored by top institutionsTreasury Yields & Real-Time Volume Triggers - newser.com
How Ikena Oncology Inc. stock performs in interest rate cycles2025 Earnings Surprises & Risk Adjusted Buy/Sell Alerts - newser.com
Is Ikena Oncology Inc. stock attractive for ETFs2025 Risk Factors & High Win Rate Trade Alerts - newser.com
Chart based exit strategy for Ikena Oncology Inc.Weekly Investment Summary & Low Risk Entry Point Guides - newser.com
Will Ikena Oncology Inc. stock attract more institutional investors2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Can Ikena Oncology Inc. stock deliver strong Q4 earningsSwing Trade & Community Consensus Picks - newser.com
Applying big data sentiment scoring on Ikena Oncology Inc.2025 Momentum Check & Daily Stock Trend Reports - newser.com
Published on: 2025-11-03 05:34:45 - newser.com
How Ikena Oncology Inc. stock performs in stagflationEntry Point & High Accuracy Swing Trade Signals - newser.com
Is Ikena Oncology Inc. stock gaining market shareTrade Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
ImageneBio, Inc. (NASDAQ:IMA) Short Interest Update - Defense World
Published on: 2025-10-30 23:13:35 - newser.com
Finanzdaten der Ikena Oncology Inc-Aktie (IKNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.89%
1.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):